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Background
Phase III clinical trials in areas including acute stroke
and traumatic brain injury commonly use ordinal func-
tional outcome scales as their primary outcome mea-
sure. Conventionally these scales are analysed by
dichotomising the ordinal scale into a binary scale:-
‘dead or dependent’ versus ‘independent’. This can
potentially discard much relevant information, reducing
both the clinical relevance of the results and the statisti-
cal efficiency of the analysis.
Methods
Methodological work in stroke (by the OAST Group)
and in traumatic brain injury (by the IMPACT Investi-
gators) has demonstrated that using more appropriate
approaches to the analysis of ordinal outcome scales,
such as proportional odds regression or the ‘sliding
dichotomy’, can potentially lead to substantial efficiency
gains relative to the conventional dichotomous analysis.
However, to date relatively few trials have prospectively
adopted ordinal techniques for their primary analysis.
We report here how in SCAST [1], a major Phase III
trial of blood pressure reduction in acute stroke, ordinal
methods were adopted for the primary analysis of the
modified Rankin Scale (mRS), an ordinal functional out-
come scale.
Results
Since ordinal methodology was evolving in parallel with
the conduct of the trial, the Statistical Analysis Plan was
not finalised until close to database lock. It was decided
to use proportional odds regression for the primary
analysis of the mRS with the sliding dichotomy as a sen-
sitivity analysis. Relative to a conventional dichotomous
analysis both of these approaches did indeed lead to
substantial efficiency gains, equivalent to more than
doubling the sample size.
Conclusions
SCAST shows that the potential efficiency gains demon-
strated in basic methodological research can be realised
in practice. This has major implications for the design
and analysis of future trials based on ordinal outcome
scales.
Acknowledgements
This work is presented on behalf of the SCAST Study Group.
Author details
1Edinburgh MRC Hub for Trials Methodology Research, University of
Edinburgh, Edinburgh, EH8 9AG, UK. 2Department of Internal Medicine, Oslo
University Hospital Ullevål, Oslo, NO-0407, Norway. 3Stroke Trials Unit,
University of Nottingham, Nottingham, NG5 1PB, UK.
Published: 13 December 2011
Reference
1. Sandset EC, Bath PMW, Boysen G, Jatuzis D, Korv J, Luders S, Murray GD,
Richter PS, Roine RO, Terent A, Thijs V, Berge E, on behalf of the SCAST
Study Group: The angiotensin-receptor blocker candesartan for
treatment of acute stroke (SCAST): a randomised, placebo-controlled,
double-blind trial. Lancet 2011, 377:741-750.
doi:10.1186/1745-6215-12-S1-A67
Cite this article as: Murray et al.: Efficiency gains resulting from the
ordinal analysis of a functional outcome scale: a case study of a major
phase III stroke trial. Trials 2011 12(Suppl 1):A67.
1Edinburgh MRC Hub for Trials Methodology Research, University of
Edinburgh, Edinburgh, EH8 9AG, UK
Full list of author information is available at the end of the article
Murray et al. Trials 2011, 12(Suppl 1):A67
http://www.trialsjournal.com/content/12/S1/A67 TRIALS
© 2011 Murray et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
